Novo - the best vaccine for your portfolio
The cost basis of the low power VLSI technician is highlighted in black. His mastery of concepts such as voltage, transistors, nanometers, electricity makes it no surprise he got in at the lows...
we will sell abve cb, -80%, but something tells me that the goldman man will be happy buying back, options at 33, will mature way in the green, as another opportunity once did present itself, at favourable prices today...
Uwaga
we keep goingUwaga
the LUNA tattoo speaks to his conviction (and insanity), the sellers are giddy, but the survival statistics are not in their favour...it is only a matter of time before they cover, only a matter of time when they buy back, the $33 constructal calls for us, the magic man controls 80% of the supply, we can waitUwaga
we have been a $14 buyer, novo with his hands in all the recent raises, polygon, luna, how can an old banker be so insaneUwaga
vaccines can sometimes bring symptoms of mild fever after injection, night sweats are not uncommonUwaga
we were a 14$ buyer again, the merchant banking angle is lucrative, already are facilitating institutional grade deals, holdings massive/growingUwaga
vacciniation has hiccups, sometimes it needs the shock to kick into gear, 3 vaccines didn't help when I got the virus, I laid in bed crying like a baby for a week, the gratz man executed the first SOL option on deribit today, this will cook, it is only a matter of timeUwaga
you have to keep getting vaccines, can't wait for our 5th, 6th, 7th vaccine, out portfolios must be immunized, we were $6 buyers, a 25% hated rally since then, as with all the crypto sphere "investors". 20k shorts trapped, then 24k longs trapped, the macro wind narrative herd psychology is following flight radars, chairman powwow's breakfast, balance sheet discrepancy is always the interesting thing with...
Powiązane publikacje
Wyłączenie odpowiedzialności
Informacje i publikacje przygotowane przez TradingView lub jego użytkowników, prezentowane na tej stronie, nie stanowią rekomendacji ani porad handlowych, inwestycyjnych i finansowych i nie powinny być w ten sposób traktowane ani wykorzystywane. Więcej informacji na ten temat znajdziesz w naszym Regulaminie.
Powiązane publikacje
Wyłączenie odpowiedzialności
Informacje i publikacje przygotowane przez TradingView lub jego użytkowników, prezentowane na tej stronie, nie stanowią rekomendacji ani porad handlowych, inwestycyjnych i finansowych i nie powinny być w ten sposób traktowane ani wykorzystywane. Więcej informacji na ten temat znajdziesz w naszym Regulaminie.